SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-036378
Filing Date
2024-02-14
Accepted
2024-02-14 16:37:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d780455dsc13ga.htm SC 13G/A 37348
  Complete submission text file 0001193125-24-036378.txt   38929
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Subject) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91921 | Film No.: 24639409
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kirn David (Filed by) CIK: 0001834021 (see all company filings)

Type: SC 13G/A